By continuing to use this website, you agree to the use of cookies described in our Cookies Policy. OK Read about our COVID-19 Response. Site Search Investor Contacts Investor Contact Investor Relations Contact Phone: 925-288-6137 E-mail: ir@cerus.com Corporate Counsel Cooley Godward LLP San Francisco, California Registrar and Transfer Agent Equiniti Trust Company 1110 Centre Pointe Curve, Suite 101 Mendota Heights, Minnesota 55120 Phone: 1-800-401-1957 Patent Counsel Morrison & Foerster LLP Palo Alto, California Auditors Ernst & Young LLP Palo Alto, California Contact Us First Name Last Name Enter Phone Number Email Enter Message Enter the code shown above. SUBMIT Global Headquarters 1220 Concord Avenue Concord, CA US 94520 +1 925.288.6000 European Headquarters Stationsstraat 79-D 3811 MH Amersfoort, Netherlands +31 (0) 33 49 60 600 Cookie Policy and Tracking Opt-out Guide Legal Privacy Policy Copyright (c) 2021 Cerus Corporation. INTERCEPT, INTERCEPT Blood System and Cerus are trademarks of Cerus Corporation. InterSol and Amicus are trademarks of Fenwal, Inc. Back to top About Cerus Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE Mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of INTERCEPT Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. Follow us on LinkedIn. INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation. Powered By Q4 Inc. 5.56.0.1 (opens in new window) About Cerus